The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects. 1996

L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
Department of Internal Medicine, University of Kuopio, Finland.

OBJECTIVE To investigate whether the improvement in insulin resistance by weight loss is associated with changes in skeletal muscle fiber composition or capillary density. METHODS Longitudinal, clinical intervention study of a 2.1 MJ diet daily for 3 weeks and 3.4 MJ diet daily for 9 weeks. METHODS Seven obese (age: 41-59 y, five men, BMI > 34 kg/m2) non-diabetic subjects. METHODS Insulin action was measured by the euglycaemic hyperinsulinaemic clamp before and after 3 and 12 weeks of the very low calorie diet. In addition, the skeletal muscle biopsies were taken before and after the 12 weeks. RESULTS During the 12 weeks, the subjects lost about 16% of body weight. The weight loss was accompanied by a nearly two-fold increase in total body glucose disposal rate (GDR; baseline vs 12 weeks: 842 +/- 91 vs 1505 +/- 242 mu mol/m2/min; p < 0.05). Most marked improvement was observed in non-oxidative component of GDR, which increased 2.7-fold as compared to baseline (292 +/- 113 vs 788 +/- 231 mu mol/m2/min; p < 0.05). However, no significant change in proportion of type II fibers as well as in skeletal muscle capillary density occurred during the study. CONCLUSIONS In obese non-diabetic subjects the improvement in insulin sensitivity induced by weight loss was not accompanied by marked changes in skeletal muscle fiber composition or capillary density. However, due to small number of subjects studied, the role of structural changes in the muscle fiber composition cannot be entirely ruled out.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
January 2003, Diabetes, nutrition & metabolism,
L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
January 1993, Diabete & metabolisme,
L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
March 2003, Atherosclerosis,
L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
October 1996, Diabetologia,
L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
September 2009, Obesity (Silver Spring, Md.),
L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
September 1977, Pflugers Archiv : European journal of physiology,
L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
November 2011, American journal of physiology. Regulatory, integrative and comparative physiology,
L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
March 2008, Journal of applied physiology (Bethesda, Md. : 1985),
L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
April 2005, Obesity research,
L Niskanen, and M Uusitupa, and H Sarlund, and O Siitonen, and L Paljärvi, and M Laakso
October 2003, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
Copied contents to your clipboard!